News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stiefel Laboratories Completes $640M Connetics Corporation (CNCT) Acquisition



12/28/2006 6:04:56 PM

Palo Alto-based Connetics (NASDAQ: CNCT) develops and sells dermatology drugs. The Hart-Scott-Rodino waiting period in the merger expired Dec. 15. In October, Connetic



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES